Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06498713 · ClinicalTrials.gov registry record · Phase 1
Patient Controlled Administration of Liquid Acetaminophen
A Phase 1 study of Pain and Pain, Postoperative, sponsored by Yale University.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT06498713 is a Phase 1 study of Pain and Pain, Postoperative that is actively recruiting participants, run by Yale University. The registered enrollment target is 24 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06498713, a Phase 1 study of Pain and Pain, Postoperative, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a proof of concept pilot study investigating the feasibility and acceptability of patient controlled oral medication administration, using the commonly used and low risk medication in the hospital, oral acetaminophen.
Conditions Studied
Interventions
- DRUG Acetaminophen 650 mg Oral Tablet
- DRUG Acetaminophen 650mg Liquid
- DEVICE CADD pump
Study Locations (1)
Connecticut
- Yale New Haven Hospital at St. Raphael's Campus - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2024-11-19 |
| Est. Completion | 2025-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06498713
The ClinicalTrials.gov registry entry for NCT06498713 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (92% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 3 interventions - of which Acetaminophen 650 mg Oral Tablet is the first listed.
NCT06498713 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT06498713 about?
NCT06498713 is a clinical study titled "Patient Controlled Administration of Liquid Acetaminophen". This is a proof of concept pilot study investigating the feasibility and acceptability of patient controlled oral medication administration, using the commonly used and low risk medication in the hospital, oral acetaminophen.
What is the current status of trial NCT06498713?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2024-11-19. Estimated completion is 2025-12.
What conditions does trial NCT06498713 study?
This clinical trial studies the following conditions: Pain, Pain, Postoperative.
What interventions are being tested in trial NCT06498713?
The interventions under investigation include: Acetaminophen 650 mg Oral Tablet (DRUG), Acetaminophen 650mg Liquid (DRUG), CADD pump (DEVICE).
Who is sponsoring clinical trial NCT06498713?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06498713 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
THC and CBD: A Controlled Human Study Probing a Harm Reduction Strategy
RECRUITING · Phase 1
-
Evaluation of the Excretion of Suzetrigine Into Breast Milk in Healthy Lactating Female Participants
RECRUITING · Phase 1
-
Ketamine Pharmacokinetics and Pharmacodynamics for Postpartum Depression and Pain After Cesarean Delivery
RECRUITING · Phase 1
-
High Potency Cannabis: Acute and Protracted Effects
RECRUITING · Phase 1
-
Phase 1 Study of SBS-147 in Healthy Adults
RECRUITING · Phase 1
-
Age-dependent Effects of Smoked and Oral Delta-9-THC
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.